Hepatobiliary Neoplasm — Trials

Hepatobiliary Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,262 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 5,262 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06915753	Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations(SURF431)	recruiting	Phase 1	125	Tyra Biosciences, IncINDUSTRY	4	Sep 23, 2026	clinicaltrials
NCT07291076	A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)	recruiting	Phase 1 / Phase 2	198	Bristol-Myers SquibbINDUSTRY